Markets › India › NSE › ALPA

Alpa Laboratories Ltd

NSE:ALPAHealthcare

₹52.25−2.26%At closeAt close · Mon 19 Oct · ≈ AED 2.02 · Market cap $12.12M

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	TTM	YoY
Revenue	1.0	1.1	0.9	1.1	1.1	1.1	1.1	+4.6%
Cost of revenue	0.6	0.8	0.6	0.7	0.9	0.9	1.0	+9.5%
Gross profit	0.3	0.3	0.3	0.2	0.2	0.1	0.1	−28.8%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Selling, general & administrative	0.1	0.1	0.1	0.1	0.2	0.1	—	—
Selling & marketing	0.0	0.1	0.1	0.1	0.0	0.0	—	—
Operating expenses	0.1	0.2	0.1	0.2	0.2	0.1	0.1	+5.0%
Operating income	0.2	0.1	0.1	0.1	0.0	0.0	(0.0)	−379.5%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	+24.3%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Other income / expense	(0.1)	0.1	0.1	0.1	0.2	0.2	—	—
Pre-tax income	0.1	0.2	0.2	0.2	0.3	0.2	0.1	−64.6%
Income tax	0.0	0.1	0.0	0.0	0.1	0.0	0.0	−9.2%
Net income	0.1	0.1	0.1	0.2	0.2	0.2	0.0	−70.8%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	(0.0)	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	3.44	6.70	5.98	8.01	9.27	7.13	2.08	−70.8%
EPS, diluted (per share)	3.44	6.70	5.98	8.01	9.27	7.13	2.08	−70.8%
EBITDA	0.1	0.2	0.2	0.2	0.3	0.2	(0.0)	−105.7%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Weighted average shares (shares)	21,040,600	21,040,600	21,040,600	20,944,444	21,044,444	21,041,000	—	—
Weighted average diluted shares (shares)	21,040,600	21,040,600	21,040,600	20,944,444	21,044,444	21,041,000	—	—
Gross margin	32.8%	31.1%	33.3%	17.4%	17.3%	12.9%	8.8%	−4.1 pts
Operating margin	21.6%	8.6%	7.3%	5.7%	2.3%	1.1%	−3.0%	−4.2 pts
Net margin	7.5%	12.8%	13.6%	15.4%	17.3%	14.2%	4.0%	−10.2 pts

INR billionsUpdated Tue 30 Jun ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.